ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

Oxaliplatin Regimens Extend Survival Of Advanced Colorectal Cancer, Study Finds

June 27, 2003

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013